Codman Pumps for Metastatic Liver Cancer Discontinued

LISA SCHULMEISTER, MN, RN, FAAN
Monday, May 14, 2018
On April 25, The New York Times (NYT) reported that Codman pumps, manufactured by Cerenovus, are no longer being produced as of April 1, because of manufacturing issues. These implanted constant-flow infusion pumps were primarily used for intrahepatic chemotherapy for colorectal liver metastasis. In addition, the NYT reports that demand for the Codman pumps was low, at around 300 pumps a year in the US.

Fortunately, there are other ways to deliver possibly life-extending intrahepatic treatment than using a totally implanted pump. Hepatic arterial infusions can be done by using either a hepatic arterial port or a percutaneously placed catheter connected to an external pump.

Both the Codman implanted and external pump approaches have associated potential complications, so appropriate patient selection and comprehensive nursing monitoring and patient education are critical.

Nurses will need to continue to care for patients who have had Codman pumps implanted, be aware that they are no longer being manufactured, and in the future, deliver care to patients with arterial catheters connected to portable external infusion pumps.

 

Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources

Blogs
Continuing Education
Discussions
Web Exclusives


About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.